// App-Quantinova.ai

: Early Onset Dementia: Clinical utility of cerebrospinal fluid Amyloidβ and tau measures in diagnosing mild cognitive impairment

Researchers

Presenter

  • Akram A. Hosseini

Principal Investigators

  • Thomas Brown

  • Luca Mannino

  • Bruno Gran

  • Kehinde Junaid

  • elizabeta mukaetova-Ladinska

Medical Centers

  • Nottingham University Hospitals NHS Trust, Queens Medical Center

  • University of Leicester

  • Nottinghamshire Healthcare NHS Foundation Trust

  • Nottingham University Hospitals NHS Trust

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

  • Alzheimer's disease

  • Dementia

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved